Iconlabs

India Founded: 2021 • Age: 5 yrs
Provides testing, imaging, and analysis of samples using electron microscopes.

About Iconlabs

Iconlabs is a company based in India founded in 2021. It operates as a B2B. The company has 1 employees. Iconlabs offers products and services including TEM Imaging, ESEM Imaging & Microanalysis, Hi-Resolution SEM Imaging & Microanalysis, Sputter Coater, and Profiler.

  • Headquarter India
  • Employees 1
  • Sectors
    Healthcare
    Technology
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website iconlabs.in
  • Social LinkedIn Instagram
  • Legal Name Icon Labs Private Limited
  • Date of Incorporation 16 Jul, 2021
  • Jurisdiction Thane, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹2.55 Cr

    FY 2024 · +152% YoY

  • Net Profit
    ₹20.9 Lakh

    FY 2024 · 8% margin

  • EBITDA
    ₹40.1 Lakh

    FY 2024 · 16% margin

  • Employee Count
    1

Products & Services of Iconlabs

Iconlabs offers a comprehensive portfolio of products and services, including TEM Imaging, ESEM Imaging & Microanalysis, Hi-Resolution SEM Imaging & Microanalysis, Sputter Coater, and Profiler.

TEM Imaging
Microscopy Service

Service for imaging samples using Transmission Electron Microscope

ESEM Imaging & Microanalysis
Microanalysis Service

Environmental Scanning Electron Microscopy for sample imaging

Hi-Resolution SEM Imaging & Microanalysis
Microscopy Service

High-resolution imaging and analysis of samples

Sputter Coater
Sample Preparation

Coating service for enhancing sample visibility

Profiler
Analytical Tool

Tool for surface profiling and analysis of materials

Board of directors of Icon Labs Private Limited (Iconlabs)

Icon Labs Private Limited is the primary company behind Iconlabs. The board of Icon Labs Private Limited currently have 2 directors; the longest-serving is Prashant Kumar Laxminarayana Arava, appointed in 2021. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Prashant Kumar Laxminarayana Arava
DIN 03108057
Director16 Jul 20215 yrs 2 moIcon Labs Private Limited
Prathyusha Prashant Kumar Arava
DIN 09465084
Director19 Feb 20224 yrs 7 moIcon Labs Private Limited

Financials of Iconlabs

Figures of Icon Labs Private Limited, the primary company behind Iconlabs, for FY 2024. Revenue was ₹2.55 Cr (+152% year on year). Net profit was ₹20.9 Lakh (8% margin). EBITDA was ₹40.1 Lakh (16% margin).

  • ₹2.55 CrRevenue · FY 2024 · +152% YoY
  • ₹20.9 LakhNet profit · 8% margin
  • ₹40.1 LakhEBITDA · 16% margin
  • ₹3.5 LakhPaid-up capital

Balance sheet, profit and loss, cash flow and ratios of Icon Labs Private Limited are on its company page.

Premium access

Detailed financial statements for Iconlabs

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Iconlabs

10 companies that operate in the same segment as Iconlabs (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pharmaceutical products are manufactured and marketed worldwide.
1891Kenilworth, Warwickshire, United Kingdom–USD 64.93 B781
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United States–USD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United States–USD 61.16 B55,000
Traditional pharmaceutical medicines are developed for multiple health fields.
1876United States–USD 65.18 B47,000
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
1987Foster City, California, United States–USD 29.45 B17,600
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
1993San Francisco, California, United StatesUSD 215.5 MUSD 29.62 M225
Developer of medical devices, generic pharmaceuticals, and nutrition products
1888Libertyville, Illinois, United States–USD 44.33 B3,710
Medicines and health products are retailed through pharmacy outlets.
2006Hyderabad, Telangana, IndiaUSD 268.78 MUSD 734.57 M25,010
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Iconlabs

Iconlabs was founded in 2021.

Iconlabs is headquartered in India.

Iconlabs has 1 employees.

The primary company behind Iconlabs, Icon Labs Private Limited, reported revenue of β‚Ή2.55 Cr for FY 2024, up 152% year on year.

IconLabs is a commercial lab specializing in microscopy services, including TEM, SEM, and microanalysis for metallurgical, biological, and chemical samples. They use advanced equipment to deliver high-quality testing and imaging. Based in Navi Mumbai, India, with liaison offices in other cities, they serve research institutes, universities, and industries in fields like nanotechnology and pharmaceuticals.

Iconlabs offers TEM Imaging, ESEM Imaging & Microanalysis, Hi-Resolution SEM Imaging & Microanalysis, Sputter Coater, and Profiler.

Iconlabs operates through Icon Labs Private Limited.

The legal entities of Iconlabs currently have 2 directors, including Prashant Kumar Laxminarayana Arava, Prathyusha Prashant Kumar Arava.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available